JP2010540658A5 - - Google Patents

Download PDF

Info

Publication number
JP2010540658A5
JP2010540658A5 JP2010528165A JP2010528165A JP2010540658A5 JP 2010540658 A5 JP2010540658 A5 JP 2010540658A5 JP 2010528165 A JP2010528165 A JP 2010528165A JP 2010528165 A JP2010528165 A JP 2010528165A JP 2010540658 A5 JP2010540658 A5 JP 2010540658A5
Authority
JP
Japan
Prior art keywords
compound
alkyl
formula
protecting group
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010528165A
Other languages
English (en)
Japanese (ja)
Other versions
JP5735277B2 (ja
JP2010540658A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/078762 external-priority patent/WO2009046308A1/en
Publication of JP2010540658A publication Critical patent/JP2010540658A/ja
Publication of JP2010540658A5 publication Critical patent/JP2010540658A5/ja
Application granted granted Critical
Publication of JP5735277B2 publication Critical patent/JP5735277B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010528165A 2007-10-03 2008-10-03 ハリコンドリンb類似体の合成のための中間体および方法 Active JP5735277B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US99762507P 2007-10-03 2007-10-03
US60/997,625 2007-10-03
PCT/US2008/078762 WO2009046308A1 (en) 2007-10-03 2008-10-03 Intermediates and methods for the synthesis of halichondrin b analogs

Publications (3)

Publication Number Publication Date
JP2010540658A JP2010540658A (ja) 2010-12-24
JP2010540658A5 true JP2010540658A5 (enExample) 2011-12-15
JP5735277B2 JP5735277B2 (ja) 2015-06-17

Family

ID=40019255

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010528165A Active JP5735277B2 (ja) 2007-10-03 2008-10-03 ハリコンドリンb類似体の合成のための中間体および方法

Country Status (11)

Country Link
US (6) US8093410B2 (enExample)
EP (2) EP2200992B1 (enExample)
JP (1) JP5735277B2 (enExample)
CN (3) CN104311571B (enExample)
BR (1) BRPI0817909B1 (enExample)
CA (1) CA2701534C (enExample)
IL (1) IL204791A (enExample)
MX (1) MX2010003599A (enExample)
RU (1) RU2489437C2 (enExample)
SG (1) SG10201811715YA (enExample)
WO (1) WO2009046308A1 (enExample)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2682878B2 (ja) 1989-11-27 1997-11-26 上村工業株式会社 シールド付き電気めっき装置
CA2755266C (en) * 1998-06-17 2014-08-12 Eisai R&D Management Co., Ltd. Intermediates for preparing macrocyclic analogs
AU2005250487B2 (en) 2004-06-03 2012-03-29 Eisai R&D Management Co., Ltd Intermediates for the preparation of analogs of halichondrin B
EP2200992B1 (en) 2007-10-03 2014-02-26 Eisai R&D Management Co., Ltd. Intermediates and methods for the synthesis of halichondrin b analogs
JP6001857B2 (ja) * 2008-04-04 2016-10-05 エーザイ・アール・アンド・ディー・マネジメント株式会社 ハリコンドリンb類似体
DE102009012660A1 (de) * 2009-03-13 2010-09-16 H.C. Starck Clevios Gmbh Polymerbeschichtungen mit verbesserter Temperaturstabilität
AU2010232347A1 (en) 2009-03-30 2011-09-29 Eisai R&D Management Co., Ltd. Liposome composition
BR112012018232B8 (pt) * 2010-01-26 2023-01-10 Eisai R&D Man Co Ltd Compostos derivados de furo [3,2-b] pirano úteis na síntese de análogos de halicondrina b e métodos de sintetização de er-80402 e de eribulina
CN102225921B (zh) * 2011-04-26 2013-04-24 中国人民解放军第二军医大学 一种环戊烷聚酮类化合物simplextone A及其用途
WO2012147900A1 (en) 2011-04-28 2012-11-01 Eisai R&D Management Co., Ltd. Microreactor process for halichondrin b analog synthesis
CA2892780A1 (en) 2012-12-04 2014-06-12 Eisai R&D Management Co., Ltd. Use of eribulin in the treatment of breast cancer
AU2014299699B2 (en) 2013-06-26 2019-10-10 Eisai R&D Management Co., Ltd. Use of eribulin and lenvatinib as combination therapy for treatment of cancer
RU2710545C2 (ru) 2013-11-04 2019-12-27 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Реакции макроциклизации и промежуточные соединения и другие фрагменты, пригодные в получении аналогов халихондрина b
MX384292B (es) 2013-12-06 2025-03-14 Eisai R&D Man Co Ltd Metodos utiles en la sintesis de analogos de halicondrina b.
EP3148526B1 (en) 2014-05-28 2021-01-06 Eisai R&D Management Co., Ltd. Use of eribulin in the treatment of cancer
JP2017520586A (ja) 2014-06-30 2017-07-27 プレジデント アンド フェローズ オブ ハーバード カレッジ ハリコンドリン類似体の合成およびその使用
EP3191479B1 (en) 2014-09-09 2020-04-08 Cipla Limited "process for the preparation of macrocyclic ketone analogs of halichondrin b or pharmaceutically acceptable salts and intermediates thereof"
AU2015384801B2 (en) 2015-03-04 2022-01-06 Eisai R&D Management Co., Ltd. Combination of a PD-1 antagonist and a VEGFR/FGFR/RET tyrosine kinase inhibitor for treating cancer
KR20170122810A (ko) 2015-03-04 2017-11-06 머크 샤프 앤드 돔 코포레이션 암을 치료하기 위한 pd-1 길항제 및 에리불린의 조합
US10344038B2 (en) 2015-04-30 2019-07-09 President And Fellows Of Harvard College Chromium-mediated coupling and application to the synthesis of halichondrins
RU2739034C2 (ru) 2015-05-07 2020-12-21 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Реакции макроциклизации и промежуточное соединение и другие фрагменты, полезные в синтезе макролидов галихондринов
KR20180107243A (ko) 2016-02-12 2018-10-01 에자이 알앤드디 매니지먼트 가부시키가이샤 에리불린의 합성에서의 중간체 및 관련된 합성 방법
RS62108B1 (sr) 2016-03-02 2021-08-31 Eisai R&D Man Co Ltd Antitelo-lek konjugati na bazi eribulina i postupci primene
EP3449921B1 (en) 2016-04-28 2023-05-31 Eisai R&D Management Co., Ltd. Eribulin for inhibiting tumor growth
US11136335B2 (en) 2016-06-30 2021-10-05 Eisai R&D Management Co., Ltd. Prins reaction and intermediates useful in the synthesis of halichondrin macrolides and analogs thereof
MX2019003994A (es) 2016-10-14 2019-09-19 Merck Sharp & Dohme Combinacion de un antagonista de proteina de muerte programada-1 (pd-1) y eribulina para el tratamiento de cancer urotelial.
JP6978758B2 (ja) 2016-11-11 2021-12-08 プレジデント アンド フェローズ オブ ハーバード カレッジ パラジウム媒介ケトール化
TWI863657B (zh) 2017-04-05 2024-11-21 哈佛大學校長及研究員協會 巨環化合物及其用途
US9938288B1 (en) 2017-04-05 2018-04-10 President And Fellows Of Harvard College Macrocyclic compound and uses thereof
US11498892B2 (en) 2017-07-06 2022-11-15 President And Fellows Of Harvard College Fe/Cu-mediated ketone synthesis
CN118515685A (zh) 2017-07-06 2024-08-20 哈佛大学的校长及成员们 软海绵素的合成
US20190046513A1 (en) 2017-08-10 2019-02-14 Huya Bioscience International, Llc Combination therapies of hdac inhibitors and tubulin inhibitors
EP4403560A3 (en) 2017-11-15 2024-10-23 President And Fellows Of Harvard College Macrocyclic compounds and uses thereof
US11419856B2 (en) 2017-11-20 2022-08-23 Basilea Pharmaceutica International AG Pharmaceutical combinations for use in the treatment of neoplastic diseases
EP3737673B1 (en) * 2018-01-03 2024-03-06 Eisai R&D Management Co., Ltd. Process for preparing halichondrin macrolides and analogs thereof by a prins reaction, and intermediates of this process
US11447499B2 (en) 2019-06-14 2022-09-20 Rk Pharma Inc. Process for the preparation of eribulin mesylate intermediate
WO2020255164A1 (en) 2019-06-21 2020-12-24 Council Of Scientific And Industrial Research A chemo-enzymatic process for the preparation of homopropargylic alcohol
US12036204B2 (en) 2019-07-26 2024-07-16 Eisai R&D Management Co., Ltd. Pharmaceutical composition for treating tumor
US11083705B2 (en) 2019-07-26 2021-08-10 Eisai R&D Management Co., Ltd. Pharmaceutical composition for treating tumor
CN110981903A (zh) * 2019-11-28 2020-04-10 南京正济医药研究有限公司 一种艾日布林中间体化合物提高光学纯度的精制方法

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2027890C3 (de) * 1970-06-06 1979-02-01 Kali Chemie Ag 8-AIkoxy oder -Benzyloxy-3-methyl-lO- methylen-2,9-dioxatricyclo-(43,l,03,7 )-decan-4-one und 8-AIkoxy oder 8-Benzyloxy-3,10-dimethyl-2,9dioxatricyclo- (43,1,O" )-decan-4-one
SU652180A1 (ru) 1975-12-16 1979-03-15 Краснодарский политехнический институт 1(Фурил-2,)-2-(2-,, формилфурил-5,, ) этилен или его метильное производное как промежуточный продукт дл синтеза фуран-2,5-дикарбоновой кислоты и способ его получени
US4086245A (en) * 1976-12-09 1978-04-25 The Upjohn Company Antibiotics 7-O-alkylnogarols
SU722912A1 (ru) * 1978-03-06 1980-03-25 Уфимский Нефтяной Институт Способ получени 5-метил/-4оксо3,6,8-триоксабицикло/ (3,2,1)-октана
US5338865A (en) * 1992-03-12 1994-08-16 President And Fellows Of Harvard College Synthesis of halichondrin B and norhalichondrin B
US5436238A (en) * 1992-03-12 1995-07-25 President And Fellows Of Harvard College Halichondrins and related compounds
GB9206244D0 (en) * 1992-03-23 1992-05-06 Pharma Mar Sa Cytotoxic compound from a marine sponge
TW255880B (enExample) 1992-09-09 1995-09-01 Hoechst Ag
US6194586B1 (en) 1996-09-06 2001-02-27 Eli Lilly And Company Selective sulphonation of the primary alcohol of a diol containing both primary and secondary alcohols
US6870058B2 (en) 1996-12-03 2005-03-22 The Trustees Of The University Of Pennsylvania Compounds which mimic the chemical and biological properties of discodermolide
US8097648B2 (en) 1998-06-17 2012-01-17 Eisai R&D Management Co., Ltd. Methods and compositions for use in treating cancer
CA2755266C (en) 1998-06-17 2014-08-12 Eisai R&D Management Co., Ltd. Intermediates for preparing macrocyclic analogs
US6653341B1 (en) * 1998-06-17 2003-11-25 Eisai Co., Ltd. Methods and compositions for use in treating cancer
DE10106647A1 (de) 2001-02-12 2002-08-22 Univ Hannover Ratjadon-Derivate zum Hemmen des Zellwachstums
AU2005250487B2 (en) 2004-06-03 2012-03-29 Eisai R&D Management Co., Ltd Intermediates for the preparation of analogs of halichondrin B
CN109180615A (zh) * 2004-06-03 2019-01-11 卫材R&D管理有限公司 用于制备软海绵素b的类似物的中间体
US20060045846A1 (en) 2004-08-30 2006-03-02 Horstmann Thomas E Reagents and methods for labeling terminal olefins
WO2006076100A2 (en) 2004-12-09 2006-07-20 Eisai Co. Ltd. Tubulin isotype screening in cancer therapy using halichondrin b analogs
JP2009510005A (ja) 2005-09-26 2009-03-12 シムライズ・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング・ウント・コンパニー・コマンジツト・ゲゼルシヤフト 分子内プリンス反応および該反応に適する触媒
WO2008010776A1 (en) 2006-07-21 2008-01-24 Agency For Science, Technology And Research Aigialomycin d and derivatives thereof and their use in treating cancer or malaria or a microbial infection
JPWO2009014105A1 (ja) 2007-07-20 2010-10-07 株式会社山田養蜂場本社 新規カルボン酸およびそれを有効成分とする抗うつ用組成物
EP2200992B1 (en) * 2007-10-03 2014-02-26 Eisai R&D Management Co., Ltd. Intermediates and methods for the synthesis of halichondrin b analogs
CA2705383A1 (en) * 2007-11-16 2009-05-22 Eisai R&D Management Co., Ltd. Novel intermediate for halichondrin b analog synthesis and novel desulfonylation reaction used for the intermediate
JP6001857B2 (ja) * 2008-04-04 2016-10-05 エーザイ・アール・アンド・ディー・マネジメント株式会社 ハリコンドリンb類似体
JP5371091B2 (ja) 2009-01-23 2013-12-18 三菱レイヨン株式会社 モノスルホン酸エステルの製造方法
BR112012018232B8 (pt) * 2010-01-26 2023-01-10 Eisai R&D Man Co Ltd Compostos derivados de furo [3,2-b] pirano úteis na síntese de análogos de halicondrina b e métodos de sintetização de er-80402 e de eribulina
WO2012147900A1 (en) 2011-04-28 2012-11-01 Eisai R&D Management Co., Ltd. Microreactor process for halichondrin b analog synthesis
WO2013078559A1 (en) 2011-11-30 2013-06-06 Alphora Research Inc. Process for preparation of (3r)-2,4-di-leaving group-3-methylbut-1-ene
WO2013142999A1 (en) 2012-03-30 2013-10-03 Alphora Research Inc. Synthetic process for preparation of macrocyclic c1-keto analogs of halichondrin b and intermediates useful therein
WO2015000070A1 (en) 2013-07-03 2015-01-08 Alphora Research Inc. Synthetic process for preparation of macrocyclic c1-keto analogs of halichondrin b and intermediates useful therein including intermediates containing -so2-(p-tolyl) groups
RU2710545C2 (ru) 2013-11-04 2019-12-27 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Реакции макроциклизации и промежуточные соединения и другие фрагменты, пригодные в получении аналогов халихондрина b
MX384292B (es) 2013-12-06 2025-03-14 Eisai R&D Man Co Ltd Metodos utiles en la sintesis de analogos de halicondrina b.
EP3191479B1 (en) 2014-09-09 2020-04-08 Cipla Limited "process for the preparation of macrocyclic ketone analogs of halichondrin b or pharmaceutically acceptable salts and intermediates thereof"
RU2739034C2 (ru) 2015-05-07 2020-12-21 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Реакции макроциклизации и промежуточное соединение и другие фрагменты, полезные в синтезе макролидов галихондринов
KR20180107243A (ko) 2016-02-12 2018-10-01 에자이 알앤드디 매니지먼트 가부시키가이샤 에리불린의 합성에서의 중간체 및 관련된 합성 방법
US11136335B2 (en) 2016-06-30 2021-10-05 Eisai R&D Management Co., Ltd. Prins reaction and intermediates useful in the synthesis of halichondrin macrolides and analogs thereof
WO2018217894A1 (en) 2017-05-24 2018-11-29 Eisai R&D Management Co., Ltd. Fluorine-labelled halichondrin derivatives and related methods of synthesis
EP3737673B1 (en) 2018-01-03 2024-03-06 Eisai R&D Management Co., Ltd. Process for preparing halichondrin macrolides and analogs thereof by a prins reaction, and intermediates of this process

Similar Documents

Publication Publication Date Title
JP2010540658A5 (enExample)
RU2489437C2 (ru) Промежуточные соединения и способы синтеза аналогов галихондрина в
JP2018172424A5 (enExample)
CN103998423B (zh) 曲伏前列素的制备方法
EP2521717A1 (en) Method for the preparation of rivaroxaban
CN1069028A (zh) 红豆杉醇侧链的不对称合成
JP2011526896A5 (enExample)
JP2021503522A5 (enExample)
CN1589263A (zh) 光学活性氧代庚烯酸酯的制备方法
JP6121492B2 (ja) (1s,4r)−2−オキサ−3−アザビシクロ[2.2.1]ヘプト−5−エンの製造方法
AU2010275780A1 (en) Preparation of (R)- and (S)-N-(3, 4-difluoro-2-(2-fluoro-4-iodophenylamino)--6-methoxyphenyl) -1- (2, 3-dihydroxypropyl)cyclopropane-1-sulfonamide and protected derivatives thereof
KR102436114B1 (ko) 신규한 이노토디올의 제조방법
CN101243062A (zh) 奈必洛尔的制备方法
JPH09263583A (ja) N−ベンジルインドールの調製法
JP2011523631A5 (enExample)
JP2008508231A5 (enExample)
JPWO2006088071A1 (ja) 抗hcv作用を有する化合物の製造方法およびその中間体
CN101842363A (zh) 制备(6r)-3-己基-4-羟基-6-十一烷基-5,6-二氢吡喃-2-酮的方法及该方法中所用的中间体
CN101842370B (zh) 手性拆分2-取代的4-取代的1,3-氧硫杂环戊烷的方法
CN1436761A (zh) 一种烷基环己基炔类液晶及其生产方法
JP3403761B2 (ja) 3,5―ジヒドロキシ―1―オクテン―7―イン類及びその製造方法
JP2020503386A (ja) エリブリンメシル酸塩の製造中間体及びその製造方法
KR20170123442A (ko) 베라프로스트 제조 중간체의 제조방법
KR101123847B1 (ko) 오셀타미비어(타미플루)의 제조 방법
JP5300713B2 (ja) 6−ヒドロキシエチルペナム化合物の製造方法